Guide to Genotyping Technologies, the Institute for Comparative Genomics, the Launch of TCGA, more | GenomeWeb

Ten years ago, Genome Technology published a guide to genotyping technologies that includes products — complete with performance and pricing information — from 21 vendors. Michael Boyce-Jacino, who was then chief technology officer at the Princeton, NJ-based Orchid BioSciences, now Orchid Cellmark, said the SNP-technology market was "early in its exploding phase" at the time GT's March 2001 issue went to press. Boyce-Jacino also predicted that many genotyping technology firms would merge. "There's definitely not room for all these companies," he told GT.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.